Robert Michael Ussery - 11 Nov 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
President & COO
Signature
/s/ Michael Ussery
Issuer symbol
NHC
Transactions as of
11 Nov 2025
Net transactions value
-$51,005
Form type
4
Filing time
13 Nov 2025, 17:51:35 UTC
Previous filing
30 Jun 2025
Next filing
18 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ussery Robert Michael President & COO 100 VINE STREET, MURFREESBORO /s/ Michael Ussery 13 Nov 2025 0001313364

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Options Exercise $242,730 +4,500 +2.8% $53.94 162,448 11 Nov 2025 Direct F1
transaction NHC Common Stock Tax liability $225,401 -1,705 -1% $132.20 160,743 11 Nov 2025 Direct F3
transaction NHC Common Stock Options Exercise $423,450 +4,500 +2.8% $94.10 165,243 11 Nov 2025 Direct F2
transaction NHC Common Stock Tax liability $491,784 -3,720 -2.3% $132.20 161,523 11 Nov 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -4,500 -50% $0.000000 4,500 11 Nov 2025 Common Stock 9,000 $53.94 Direct F1
transaction NHC Option to Purchase Common Stock Options Exercise $0 -4,500 -33% $0.000000 9,000 11 Nov 2025 Common Stock 13,500 $94.10 Direct F2
holding NHC Option to Purchase Common Stock 15,000 11 Nov 2025 Common Stock 15,000 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
F4 Total amount of shares beneficially owned following transactions reported on this form.